Anti-miRNA-based therapeutics for Mammary, ovarian, renal & liver cancer: The OncomiR miR-17-92 suppresses the expression of BDGI via down regulation of its target gene, 15/May/2014, 5.09 am

Therapeutic insights into the treatment of glucose intolerance and insulin resistance: c-Myc protects against TIIDM via down regulation of its target gene, 15/May/2014, 4.59 am
May 14, 2014
Vitamin-based anticancer therapy: 1,25-dihydroxyvitamin D increases the expression of tumor suppressor KRIT1/CCM1 via up regulation of its target gene, 15/May/2014, 5.27 am
May 14, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, L., Anti-miRNA-based therapeutics for Mammary, ovarian, renal & liver cancer:  The OncomiR miR-17-92 suppresses the expression of BDGI via down regulation of its target gene, 15/May/2014, 5.09 am Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

 

Comments are closed.